NCT01723384View on ClinicalTrials.gov

Intermittent Naltrexone Among Polysubstance Users

PHASE2CompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

May 31, 2013

Primary Completion Date

October 31, 2014

Study Completion Date

November 30, 2014

Conditions
MethamphetamineAlcohol
Interventions
DRUG

Intermittent Oral Naltrexone

DRUG

Placebo

Trial Locations (1)

94102

San Francisco Department of Public Health, Substance Use Research Unit, San Francisco

All Listed Sponsors
collaborator

National Institute on Drug Abuse (NIDA)

NIH

lead

University of California, San Francisco

OTHER

NCT01723384 - Intermittent Naltrexone Among Polysubstance Users | Biotech Hunter | Biotech Hunter